Sigyn Therapeutics (OTCMKTS:SIGY) Shares Up 5.3% – Should You Buy?

Sigyn Therapeutics, Inc. (OTCMKTS:SIGY)’s share price was up 5.3% during trading on Thursday . The company traded as high as $2.00 and last traded at $2.00. Approximately 154 shares changed hands during mid-day trading, a decline of 55% from the average daily volume of 345 shares. The stock had previously closed at $1.90.

Sigyn Therapeutics Stock Up 5.3%

The company has a market cap of $3.22 million, a price-to-earnings ratio of -0.42 and a beta of -0.88. The business has a fifty day simple moving average of $2.78 and a 200 day simple moving average of $2.96.

Sigyn Therapeutics Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 21st. Investors of record on Friday, October 24th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $1.28 dividend on an annualized basis and a yield of 64.0%.

Sigyn Therapeutics Company Profile

Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.